• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Sequent Medical

Terumo’s MicroVention wins FDA approval for Web brain aneurysm device

January 7, 2019 By Brad Perriello

Terumo (OTC:TRUMY;TYO:4543) subsidiary MicroVention said today that it won pre-market approval from the FDA for the Web brain aneurysm device it acquired when it bought Sequent Medical back in 2016. Aliso Viejo, Calif.-based MicroVention said the PMA for the Web embolic coil covers the treatment of intracranial wide neck bifurcation aneurysms. “We are proud to offer […]

Filed Under: Featured, Food & Drug Administration (FDA), Neurological, Regulatory/Compliance Tagged With: MicroVention-Terumo Inc., Sequent Medical, Terumo

Terumo closes $280m Sequent Medical buyout

July 14, 2016 By Brad Perriello

Terumo Corp. (TYO:4543) said today that its MicroVention subsidiary closed the $280 million acquisition of Sequent Medical and its Web aneurysm embolization device. The Web implant is made of a Nitinol mesh that is delivered in a “stent-like” manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. Sequent […]

Filed Under: Mergers & Acquisitions, Neurological, Wall Street Beat Tagged With: MicroVention-Terumo Inc., Sequent Medical, Terumo

Terumo buys Sequent Medical for $280m

June 14, 2016 By Fink Densford

Terumo Corp. (TYO:4543) said today it picked up Sequent Medical, developer of the Web aneurysm embolization device, for $280 million. The Web implant is made of a Nitinol mesh that is delivered in a “stent-like” manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in.  Sequent won […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Neurological, Vascular Tagged With: Sequent Medical, Terumo

Sequent wins FDA nod to add smaller Web device to IDE trial

October 12, 2015 By Fink Densford

Sequent Medical said today it won clearance from the FDA to add its smaller .021″ Web aneurysm embolization system to its investigational device exemption trial. The smaller .021″ version is the latest generation Web device from the Aliso Viejo, Calif.-based company, delivered through a smaller version of its VIA microcatheter. The Web implant is made of a […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Implants, Vascular Tagged With: Sequent Medical

Ex-ConMed exec is Interventional Spine’s new Darling | Personnel Moves

July 8, 2015 By Fink Densford

Interventional Spine said it has tagged ex-ConMed executive and 25-year medical veteran Joseph Darling as its new vice president and COO. Darling spent 7 years with ConMed, serving as the COO, executive veep and prez of ConMed Linvatec until February this year. Before his time at ConMed, Darling worked with Smith & Nephew, Wyeth-Ayerst Pharmaceuticals, Baxter […]

Filed Under: Business/Financial News Tagged With: CasMed Medical Systems, ConMed Corp., Dynatronics Corp, Global Kinetics Corp., Interventional Spine Inc, McKesson Corp., Medtronic, Sequent Medical, Tearlab Corp.

Sequent Medical CEO Wilder bets on MicroBraids

October 27, 2014 By Brad Perriello Leave a Comment

Sequent Medical CEO Wilder bets on braids

Filed Under: News Well Tagged With: MassDevice Q&A, Neurovascular repair, Sequent Medical

Sequent launches U.S. clinical trial of brain aneurysm device

August 29, 2014 By Arezu Sarvestani Leave a Comment

Sequent launches U.S. clinical trial of brain aneurysm device

Medtech company Sequent Medical enrolled the 1st 4 patients in a new U.S. clinical trial aimed at winning FDA approval for its Web aneurysm protection implant.

The Web implant is made of a Nitinol mesh that is delivered in a "stent-like" manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. The device already has approve in the European Union.

Filed Under: Implants, News Well, Vascular Tagged With: Clinical Trials, Investigational Device Exemption (IDE), Sequent Medical

DOD hands out $99.6 million in contracts to Hologic, GE, PositiveID | Medtech funding stories for the week of Apr. 7, 2014

April 11, 2014 By MassDevice Leave a Comment

Hologic, GE, PositiveID land near $100M in Defense contracts

April 7, 2014 by Arezu Sarvestani

Hologic, GE, PositiveID lands nearly $100M in Pentagon contracts

Filed Under: Funding Roundup, News Well Tagged With: Cytomedix Inc., Deerfield Management, defensedepartment, Delphi Ventures, Domain Associates, Foresite Capital, GE Healthcare, Hologic, PositiveID Corp., reflexion-health, Sequent Medical, Sofinnova Partners, US Venture Partners, Venrock, Versant Ventures

Sequent Medical raises $20M Series D for brain aneurysm device

April 8, 2014 By Brad Perriello Leave a Comment

Sequent Medical raises $20M Series D for brain aneurysm device

Sequent Medical said it raised a Series D round worth $20 million from its slate of previous investors, led again by Delphi Ventures.

Domain Associates, US Venture Partners and Versant Ventures also participated, Sequent said.

Filed Under: Funding Roundup, News Well Tagged With: Delphi Ventures, Domain Associates, Neurovascular repair, Sequent Medical, US Venture Partners, Venture Capital/Private Equity, Versant Ventures

St. Jude Medical rebounds after “Greek tragedy” | Wall Street Beat

March 7, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Shares of St. Jude Medical (NYSE:STJ) clawed back some of the value lost yesterday in what 1 waggish analyst termed a “Greek tragedy.”

STJ shares closed down 3.3% yesterday at $39.96 when the company revealed a $56 million writedown after a Greek distributor failed to pay up for an estimated 2 years worth of sales.

Filed Under: News Well, Wall Street Beat Tagged With: Advanced Cell Technology Inc., Allezoe Medical Holdings, Amgen, Baxter, BG Medicine Inc., CareFusion Corp., GE Capital, Hillrom, MAKO Surgical Corp., Micromet, Nordion Inc., Nuance Communications Inc., Sequent Medical, stjudemedical, Syneron Medical Ltd., Transcend Services, TransPharma Medical, Zeltiq

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS